Harvest Portfolios Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$74M Buy
340,348
+61,352
+22% +$13.6M 1.22% 22
2025
Q4
$63.7M Sell
278,996
-6,573
-2% -$1.5M 1.11% 26
2025
Q3
$66.1M Sell
285,569
-11,259
-4% -$2.29M 1.22% 17
2025
Q2
$55.1M Buy
296,828
+29,570
+11% +$5.5M 1.28% 28
2025
Q1
$56M Sell
267,258
-35,530
-12% -$6.91M 1.65% 16
2024
Q4
$53.8M Buy
302,788
+29,577
+11% +$5.44M 1.79% 9
2024
Q3
$54M Sell
273,211
-53,058
-16% -$9.9M 1.79% 20
2024
Q2
$56M Sell
326,269
-1,266
-0.4% -$210K 2.14% 7
2024
Q1
$59.6M Sell
327,535
-24,564
-7% -$4.23M 2.33% 5
2023
Q4
$54.6M Sell
352,099
-14,149
-4% -$2.06M 2.31% 11
2023
Q3
$54.6M Buy
366,248
+6,266
+2% +$920K 2.58% 4
2023
Q2
$48.5M Buy
359,982
+24,690
+7% +$3.62M 2.23% 20
2023
Q1
$53.4M Buy
335,292
+36,172
+12% +$5.53M 2.62% 5
2022
Q4
$48.3M Buy
+299,120
New +$45.9M 2.78% 6

Other funds holding ABBV

Harvest Portfolios Group's ABBV Position: Q1 2026 in Review

Harvest Portfolios Group increased its AbbVie (ABBV) stake by 22% in Q1 2026, buying an estimated $13.6M and bringing the position to 340,348 shares worth $74M. The position accounts for 1.22% of the portfolio, ranked #22.

Harvest Portfolios Group first reported a position in ABBV in Q4 2022 and has held it in 14 quarters since. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Harvest Portfolios Group held 340,348 shares of AbbVie worth $74M as of Q1 2026.
  • Harvest Portfolios Group bought 61,352 AbbVie shares in Q1 2026, an estimated $13.6M.
  • AbbVie made up 1.22% of Harvest Portfolios Group's portfolio in Q1 2026, its #22 holding.
  • Harvest Portfolios Group first reported a position in AbbVie in Q4 2022 and has held it in 14 quarters since.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Harvest Portfolios Group's 13F filing for Q1 2026, filed 14 May 2026.